Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Zeleciment Basivarsen Targets the Underlying Cause of DM1 to Enable Functional Improvement in the Phase I/II ACHIEVE Trial

Author:Andersson, Shauna   Bassez, Guillaume   Diaz-Manera, Jordi   Lilleker, James   Mul, Karlien   pane, marika   Roxburgh, Richard   Schoser, Benedikt   Turner, Chris   Ray, Soma   Chen, Huaihou   Kerr, Douglas   Sansone, Valeria   

Session Name:S7: Updates on Muscle Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S7.001  

Author Institution:Dyne Therapeutics, MA  Faculte De Medecine De Creteil, Creteil, France  Newcastle University, Newcastle, United Kingdom  University of Manchester, Manchester, United Kingdom  Radboud University Medical Center, Nijmegen, Netherlands  Fondazione Policlinico Universitario A. Gemelli, Rome, Italy  Auckland Hospital, Auckland, New Zealand  Friedrich-Baur-Institute, Dep. of Neurology LMU Clinics, Ludwig-Maximilians University, Munich, Germany  University College London Hospitals, London, United Kingdom  The NeMO Clinical Center - Neurorehabilitation Unit, University of Milan, Milan, Italy